SBC Medical Group (SBC) Fair Value & Analysis
Industrials · US · Market cap $303M
SBC Medical Group
SBC · US
Fair value as of: Jul 25, 2026
From 22 valuation models · updated 17 days ago
Share price +3.0% over the past month.
A solid business, screening 135% undervalued on our models.
What matters now
- The price is below even our cautious bear case ($5.45). The market is more pessimistic than our downside scenario.
- Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 25, 2026.
How to read this chart
46‑month range $2.87 – $16.00 · fair‑value band $5.45 – $9.09 · the $3.06 price screens below the $7.20 fair value. Dashed = 300-day average. As of Jul 25, 2026.
Analysis
SBC Medical Group (SBC) currently trades at $3.06, while our model-based Fair Value estimate is $7.20, implying the stock looks roughly 135.3% undervalued today. The Quality Score stands at 54/100 (solid quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, SBC Medical Group generated revenue of $169M at a net margin of 24.1%. Revenue declined 9.0% year over year. It earns a return on equity of 16.5%. The balance sheet holds a net cash position of $112M. Fundamentals as of Jul 25, 2026
Our scenario range runs from $5.45 (bear case) to $9.09 (bull case); at $3.06, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 47% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -15% fair-value upside, at 135%, SBC screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 22 models by family
Widest divergence: Multiples ($8.45) versus Asset-Based ($1.62). Highest evidence: Growth DCF (80).
Notify me when SBC reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 25, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 57 · Market factors (momentum, volatility) 23
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.
Full company description
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
SBC Medical Group reported revenue of $174M in FY2025 versus $174M in FY2022, a compound −0.1%/yr. Reported net income was $51.0M in FY2025, compounding +100.6%/yr from FY2022.
Watch SBC: get an alert when its fair value changes →
Peer Group
Consulting Services · 82 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Consulting Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Consulting Services stocks, each showing price versus our Fair Value estimate (as of Jul 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Verisk Analytics, Inc VRSK | $201.49 | $145.58 | -28% |
| SGS SA SGSN | CHF 94.68 | CHF 68.96 | -27% |
| Equifax Inc EFX | $177.08 | $101.34 | -43% |
| Bureau Veritas SA BVI | €27.20 | €27.81 | +2% |
| ALS Limited ALQ | A$21.96 | A$11.02 | -50% |
| Booz Allen Hamilton Holding BAH | $63.94 | $120.62 | +89% |
| DKSH Holding DKSH | CHF 67.60 | CHF 64.81 | -4% |
| FTI Consulting, Inc FCN | $156.86 | $171.64 | +9% |
| Centre Testing International Group 300012 | ¥14.06 | ¥11.90 | -15% |
| GRG Metrology & Test Group 002967 | ¥16.56 | ¥11.69 | -29% |
Compare SBC Medical Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is SBC Medical Group (SBC) overvalued or undervalued?
What is the fair value of SBC?
What is the quality score of SBC?
What is the revenue of SBC Medical Group (SBC)?
What is the net profit margin of SBC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track SBC Medical Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.